Swindon girl with Batten Disease will continue to get vital drug
A family has been told their child will continue to get access to a drug which she began taking as part of a trial, and is helping to keep her alive.Nine-year-old Addy Clarke, from Swindon, has Batten Disease - a rare degenerative disease that has no cure.An agreement has been reached that existing patients will continue to have the drug Brineura, which costs £500,000 per patient per year, via the NHS.However, it has not been recommended for future patients "due to its high price and the limited evidence of long-term effectiveness", said the National Institute for Health and Care Excellence (NICE).
Addy's mother Hayley Clarke said she is "absolutely thrilled and relieved and so thankful" at the news but wants to get access to the drug for other children.
"There's still another half a fight to go to get it secured for all children, future children most importantly," she added.She said the family could have lost Addy by now, that she should be blind, but her eyesight has been preserved and she can still make herself understood.One of the main symptoms of Batten Disease is childhood dementia.
"We're just so thankful for the time that this drug is giving us with her," said Hayley, who also told the BBC about her daughter's passions for lions and swimming."I think I'm still processing that it's a yes for our daughter," she added."[I'm] almost trying to be really guarded with hope because we've had too much shattered hope along the way."Hayley said the family has had a lot of support from people around them as well as local hospice charities and the council.
The family went with other with members with Batten Disease to Westminster to ask for continued access to Brineura.Draft guidance from NICE did not recommend using it for future patients due to cost and long-term effectiveness, but said it had reached a deal with the NHS and manufacturer BioMarin for those already using it and anyone signed up by the end of 2025. Helen Knight, director of medicines evaluation at NICE said: "We know this is not entirely the news people in the Batten Disease community were hoping for. However, this is not the end of the story. We will continue to work with all parties towards a solution."The charity Batten Disease Family Association said it was pleased with the agreement, but said as the NICE guidance is a draft and not final, it will continue to push to make Brineura accessible to all children who need it.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
34 minutes ago
- The Sun
The 4 signs of skin cancer beyond moles as Atomic Kitten's Natasha Hamilton reveals diagnosis after ‘itch on her back'
ATOMIC Kitten's Natasha Hamilton opened up about her skin cancer battle, revealing she was diagnosed with the disease after getting a persistent itchy spot on her back. In an emotional Good Morning Britain interview, the singer, 42, revealed she'd had basal cell carcinoma (BCC). 9 9 BCC is the most common skin cancer type in the UK. It begins in the basal cells — a type of cell within the skin that produces new skin cells as old ones die off - and is more likely to develop on skin regularly exposed to the sun, like the face, head or neck. The cancer often tends to appear as a pearly lump, but it can also develop as a scar-like patch on the skin or rough, scaly growths. Natasha initially mistook the diseased patch of skin as a mosquito bite. She told her hosts Kate Garraway and Rob Rinder that she developed an itch after catching a bit too much sun while on holiday in Majorca. Natasha said: "So I had been on holiday, I wasn't actually in the sun a lot, my baby was only about five months old and I was breastfeeding. "One afternoon I had her on my lap, my back was in the sun and I burnt. "I don't know if it was later that day or the next day, I had an itchy spot on my back. "I felt it, I went "oh mosquito bite". 'It wasn't until four weeks later when I was at home and it was itching I was like 'hang on a minute, that seems a bit long for a mosquito bite'. 'I asked my husband to have look and he went "oh that's not a bite," he took a picture. Natasha revealed: "Originally it had just been a dark freckle that I'd had on my back for many years. "It wasn't even raised, it wasn't a mole, it was just a freckle." The star sought specialist help and was diagnosed with BCC. 9 9 9 She was able to have the cancerous skin removed and is now living cancer-free. But she revealed: "Now I have to be really vigilant, I have to check my skin all the time. "Since then I've had a few things appear where I've had to go back to the dermatologist, they're on the 'watch list'. "This is probably something I am going to have to keep an eye for the rest of my life," Natasha said. The 4 signs of BCC When you think of signs of skin cancer, a mole probably comes to mind. This is usually the case with melanoma, the deadliest form of the disease. But non-melanoma skin cancer - which includes BCC - can manifest in other more subtle ways. According to Macmillan Cancer Support, a BCC might have some of these features: A smooth, firm lump that may be pearly, pink, red, brown or black – on black or brown skin, it is more likely to be pearly, brown or black A lump that is sunken in the middle like a crater A flat patch of scaly, crusty or irritated skin A scar-like area of pale, shiny skin This type of skin cancer tends to be painless but it can cause itchiness or bleeding. 9 9 9 Over time, a BCC may develop into an open sore that does not heal. Any part of your skin can be affected, but it's most common in areas exposed to the sun, such as the: Head, face and ears Neck and shoulders Back Hands Lower legs BCCs mainly people with fair skin, but those with other skin types may also be at risk, according to the British Skin Foundation. Those with the highest risk of developing a basal cell carcinoma are: People with pale skin who burn easily and rarely tan Those who have had a lot of exposure to the sun, such as people with outdoor hobbies or outdoor workers, and people who have lived in sunny climates People who have used sun beds or have regularly sunbathed. People who have previously had a basal cell carcinoma Almost all cases of BCC can be cured and it's almost never a danger to life, according to the charity. However, if a BCC is not treated early, it may get larger and may be more likely to come back. Treatment can include surgically removing the affected area of skin. There are two main types of skin cancer - non melanoma skin cancer and melanoma skin cancer. Non melanoma skin cancer includes: Basal cell skin cancer - this is also called basal cell carcinoma (BCC) Squamous cell skin cancer - this is also called squamous cell carcinoma (SCC) Some other rare types Non melanoma skin cancers tend to develop most often on skin that's exposed to the sun. There is a high cure rate for these cancers. Most people only have minor surgery and don't need further treatment. Melanoma skin cancer is when abnormal cells in the skin start to grow and divide in an uncontrolled way. It starts in skin cells called melanocytes. These cells are in the deep layer of the epidermis. Around 17,500 people are diagnosed with melanoma skin cancer in the UK each year. The number of people diagnosed has increased over the last few decades. Melanoma skin cancer is the fifth most common cancer in the UK.
Daily Mail
38 minutes ago
- Daily Mail
Statins slash death from terrifying 'hidden' condition that kills 48,000 a year by 40 per cent, new study finds
Taking statins can improve the chances of surviving 'hidden' killer sepsis by 40 per cent, a major new trial has found. Sepsis can occur when the body's immune system—which usually helps to fight infection—overreacts to an infection and attacks its own organs. It is notoriously difficult to spot as the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins are cholesterol-busting drugs that prevent heart attacks and strokes and are taken by around 5million adults in the UK. Experts have said they also have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The latest study compared survival rates of sepsis patients who were given statins, and those who didn't, during a hospital stay. It found the cholesterol-busting pills reduced risk of death for those with the life-threatening condition by 39 per cent. In the intensive care unit, 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. It also helped survival rates for those no longer in a critical condition—11 per cent of sepsis patients in this group given statins died compared to 19 per cent who were not. Meanwhile, those who were prescribed statins had a slightly longer stay in hospital than those who didn't—an average of 10 days compared to eight. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' The research team have called for larger trials to confirm their findings—which was based on a data from thousands of patients at a hospital in Israel over a decade. In response UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, added: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' The study is the latest to find statins, one of the most commonly prescribed medications in the UK, could have other health benefits beyond controlling cholesterol. Earlier this year researchers found taking the pills, which cost mere pennies a tablet, could also slash dementia risk—even in patients who don't have high cholesterol. Sepsis, known as the 'silent killer', strikes with frightening speed and, for every hour of delay, a patient's chance of dying increases 8 per cent. If caught early enough, it can be easily treated with intravenous antibiotics and fluids, but these must be given as soon as sepsis is suspected. The early symptoms of sepsis can be easily confused with more mild conditions, meaning it can be difficult to diagnose. A high temperature, chills and shivering, a fast heartbeat and rapid breathing are also indicators. A patient can rapidly deteriorate if sepsis is missed early on, so quick diagnosis and treatment is vital–yet this rarely happens. In the early stages, sepsis can be mistaken for a chest infection, flu or upset stomach. It is most common and dangerous in older adults, pregnant women, children younger than one, people with chronic conditions or those who have weakened immune systems. The six potential signs of the deadly condition can be identified by the acronym 'SEPSIS'. Slurred speech or confusion, Extreme shivering or muscle pain, Passing no urine in a day, Severe breathlessness, and Skin that's mottled or discoloured. Anyone who develops any of these symptoms should seek medical help urgently—and ask doctors: 'Could this be sepsis?'
Belfast Telegraph
an hour ago
- Belfast Telegraph
Hair stylist hits out at inability to bid for NHS wig contracts: ‘If I had a shot it would grow my business'
The Department of Health has confirmed to this newspaper that there is currently 'no regional tendering process' in place for hairdressers here. Individuals can access free wigs through Health and Social Care services but, since 2015, only two hairdressers in the entire region have been permitted to supply wigs for NHS patients, it has been revealed. Wigs are used by patients undergoing chemotherapy or with hair loss conditions but, due to red tape, there hasn't been a procurement exercise for three years. One Health and Social Care Trust said that the 'non-existence of a product specification' and the 'lack of national and international standards for wigs' is the reason for this. It comes after a Co Down hairdresser — who has been in the business for more than 30 years and does not wish to be named — said that it is 'not fair' that the process for the tender is essentially closed to newcomers. 'Some wigs can cost up to £2,000. And if I had a chance of securing this tender, some of my customers could have easier access to wigs they're entitled to under the NHS,' she told the Belfast Telegraph. 'This problem desperately needs solved but the Health Department and the Trusts aren't providing a clear pathway on how to solve this issue. 'If I had a shot at it, at least for one year, it would grow my business and allow me to hire more people. But this means no one else gets a chance. 'A lot of my customers find that the wigs help with their confidence after experiencing hair loss. It's hard for them to cope; losing your hair can be a loss of your femininity.' News Catch Up - Thursday 5 June A spokesperson for the Department of Health said that agreement on tenders is based on a 'locally agreed criteria' through individual health and social care trusts in Northern Ireland. 'The Department of Health does not have a role in procurement of these services,' they said. 'Availability of such services is determined at Trust level and arrangements are in place to offer appliances in line with locally agreed criteria.' The South Eastern Trust, where the hairdresser has based their business, however, said that since 2022 a procurement exercise to determine who is awarded the tender was stood down. 'The non-existence of a product specification and lack of national/international standards for wigs currently means that a regional tendering process has not been possible,' a spokesperson said. 'A procurement exercise in 2022 was stood down mainly due to a lack of a suitable product specification and national standards for the supply of wigs. 'This resulted in the procurement panel not being able to evaluate bids from a value for money perspective.' The South Eastern Trust revealed: 'As a result, all five Health and Social Care Trusts (HSCTs) in NI are exploring the opportunity to reform wig provision. 'Legal advice sought back in 2022 indicated that due to current NI legislation and subsequent policy position, all HSCTs were limited in any changes they could make to how wigs were to be procured. 'Trust representatives, together with the DoH, have been progressing work to establish a way forward for the future supply of wigs, which will include consideration of procurement options by Procurement and Logistics Service and any legislative or policy changes required. 'In the meantime, all HSCTs have been using the services of one of two providers that had successfully tendered for the 2015 Wigs and Associated Products contract. 'A regional commissioning position on the provision of wigs across NI, encompassing cancer services, dermatology and psychiatry, is required to support implementation of any proposed change to the current process.'
